RA Capital Management is a Boston-based investment firm founded in 2004 that makes public and private investments in healthcare. See contact routes.
RA Capital Management is a Boston-based investment firm founded in 2004 that makes public and private investments in healthcare, biotechnology, and planetary health industries. The firm employs an evidence-based, science-led investment thesis across all stages, targeting companies developing drugs, medical devices, diagnostics, services, and research tools primarily in the United States and Europe. RA Capital operates as a hybrid manager combining venture capital and long/short hedge fund strategies, though specific typical check sizes and lead/follow behavior are not explicitly detailed in available sources. Notable portfolio companies include Moderna Therapeutics, Bluebird Bio, 89bio, and Audentes Therapeutics, with the firm having led 28 of its 114 total investments as of December 2019. The firm distinguishes itself through its commitment to "evidence-based investing" and has expressed a growing interest in climate and sustainability technologies alongside its core healthcare focus. RA Capital maintains offices in Boston, San Francisco, and New York, and directs startup pitches through a centralized hub team at request@racap.com.
Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with comparable investors when building a target list.
Investors like RA Capital Management · Full investor directory · Investor access · Company funding database